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ABSTRACT
Introductions: Nowadays dengue infection is at present one of the most common mosquito-borne 
viral diseases of humans worldwide. Initially, Dengue infections were primarily recorded when they 
occurred as epidemics in tropical and subtropical countries. Monocyte/macrophage infection is central 
to the pathogenesis of dengue fever and to the origin of dengue hemorrhagic fever. Increased activation 
of monocytes and greater numbers of DEN-infected cells were associated with more severe Dengue, 
implicating a role for monocyte activation in dengue immunopathogenesis. Thus, more knowledge 
about the relation between numbers of activated monocyte with dengue severities is essential for better 
understanding regarding this subject.
Objectives: Studying the relation between numbers of activated monocyte, marked by HLA-DR marker 
intensity with Dengue Fever severity throughout the disease course, from day 2 until day 6 of acute dengue 
fever.
Methods: This research is cross sectional observational study. The location in done at Dr. Sardjito Hospital 
in 6 months time.
Results: There is a negative correlation between median number of activated monocyte with dengue 
severity, on day 3 of acute dengue fever.
Conclusion: There was a negative correlation between numbers of activated monocyte marked by HLA-
DR intensity with disease severity on day 3 of acute dengue infection.
Keywords: Activated Monocyte; Human Leukocyte Antigen (HLA)-DR intensity; Percentage of Activated 
Monocyte; Dengue Fever Severity.
INTISARI
Pendahuluan: Infeksi Dengue saat ini merupakan penyakit virus yang dibawa nyamuk yang tersering pada 
manusia di seluruh dunia. Monosit berperan penting pada patogenesis infeksi Dengue dan terjadinya DHF. 
Jumlah monosit terinfeksi Dengue berhubungan dengan derajat keparahan Dengue yang lebih berat, 
yang mengindikasikan adanya peranan monosit teraktivasi pada imunopatogenesis Dengue. Untuk 
membuktikan hubungan monosit teraktivasi dengan derajat infeksi Dengue diperlukan studi kinetik 
aktivasi monosit selama fase akut infeksi Dengue. 
Tujuan:  Meneliti hubungan antara jumlah monosit teraktivasi yang ditandai dari intensitas penanda HLA-
DR dengan derajat demam Dengue selama fase akut infeksi Dengue.
Metode: Penelitian observasional potong lintang ini dilakukan di RSUP dr. Sardjito selama 6 bulan dengan 
subyek 32 orang, terdiri dari 17 orang Dengue Fever (53,1%) dan Dengue Hemorrhagic Fever (DHF) 15 
orang (46,9%). Sampel darah tepi pasien diambil pada hari kedua demam sampai hari keenam. Monosit 
teraktivasi diukur secara flowcytometrik dengan mengukur intensitas ekspresi HLA-DR pada membran 
monosit. Hubungan antara monosit teraktivasi dengan keparahan infeksi Dengue dianalisis dengan 
korelasi Spearman dan independent t-test. 
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Hasil: Tidak terdapat perbedaan persentase monosit teraktivasi pada hari kedua sampai hari keenam. 
Terdapat korelasi negatif (r=-0,35; p=0,05) antara median jumlah monosit teraktivasi dengan derajat 
keparahan Dengue hanya pada hari ketiga demam Dengue akut. Rerata intensitas HLA-DR pada monosit 
lebih tinggi secara bermakna pada infeksi Dengue ringan dibandingkan DHF pada hari kelima.
Simpulan: Monosit teraktivasi pada fase akut infeksi Dengue dan mungkin berperan pada infeksi Dengue 
Kata kunci: infeksi Dengue derajat keparahan Dengue monosit teraktivasi, intensitas Human Leukocyte 
Antigen (HLA)-DR
INTRODUCTION
Dengue infections are at present one of the 
most common mosquito-borne viral diseases of 
humans worldwide. Initially, dengue infections 
were primarily recorded when they occurred as 
epidemics in tropical and subtropical countries. 
But over time, increasing globalization and 
human movement coupled by the increase in 
the geographic area where the Aedes aegypti 
mosquito vector inhabit, has promoted dengue 
virus (DEN) infection to nearly every corner of 
the world. Approximately 50 to 100 million 
people contract dengue fever annually, and 
about 200,000 to 500,000 contract dengue 
hemorrhagic fever (DHF), and the mortality rate 
is about 5%, predominantly in children under 15 
years of age 1.
Monocyte/macrophage infection is central 
to the pathogenesis of dengue fever and to the 
origin of DHF/DSS (Dengue Shock Syndrome). 
Previous infection with a heterologous dengue-
virus serotype may result in the production 
of nonprotective antiviral antibodies that 
nevertheless bind to the virion’s surface and 
through interaction with the Fc receptor focus 
secondary dengue viruses on the target cells 2. 
Recent studies showed that using monoclonal 
antibodies to structural and nonstructural DEN 
proteins, activated monocytes (CD86+, CD32+, 
CD14+, CD11c+) were the main target for DEN 
infection regardless of immune status. There is 
also significant increase in monocytes activation 
(CD86+) and a higher prevalence of CD32+, CD14+, 
CD11c+, and DEN prM+ cells in DHF patients 
compared with DF patients. Thus, increased 
activation of monocytes and greater numbers 
of DEN-infected cells were associated with more 
severe dengue, implicating a role for monocytes 
activation in dengue immunopathogenesis 3.
MATERIALS AND METHODS
This research uses the cross sectional 
observational study. The location took place at 
Sardjito Hospital in 6 months time. The subject 
being used was the patient admitted to Sardjito 
Hospital and suspected of having dengue infection 
according to the WHO criteria.This research was 
conducted from May 2010 until October 2010 at 
Dr. Sardjito Hospital, Yogyakarta.
The inclusion criteria were the subjects aged 
more than 14 years old and suspected to have 
dengue infection with NS-1 positive (+ve). The 
exclusion criterion was the subjects who are 
also suffering from other diseases, other than 
dengue infection.
Blood sample was taken from patient 
admitted to Sardjito Hospital and suspected of 
having dengue infection with NS-1 positive. Blood 
was taken aseptically by vein puncture and put 
into K3 EDTA Vacutainer blood collection tube.
The blood sample was kept in a room 20o 
– 25o C. The sample was sent to the Pathology 
Clinic Laboratory for complete blood test using 
the hematology analyzer. After that, analysis 
of HLA-DR activation marker was done by flow 
cytometric. The reagent used to detect activated 
monocyte was CD8 FITC/ HLA-DR /45 per CP 
antibody. The flowcytometric readings were 
recorded using the Cell Quest method. 
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We calculated the demographic features 
of the participant on the classification of the 
dengue infection. Next, result obtained was 
recorded in terms of median number and 
percentage of activated monocyte. Here 
the descriptive analysis was done where the 
kinetics of activated monocyte was observed. 
Spearman’s Correlation Test was conducted to 
see the correlation between number of activated 
monocyte, marked by HLA-DR intensity and 
percentage of activated monocyte with dengue 
severity for each day throughout the hospital 
admission (day 2 until day 6). Independent t-test 
was also done to observe any different between 
numbers of activated monocyte with dengue 
severity from day 2 until day 6.
RESULTS AND DISCUSSIONS
Table 1 shows that 53.1% of the subjects 
tested were classified under dengue fever and 
46.1% under dengue hemorrhagic fever, which 
consist of DHF patient grade 1 and grade 2.
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severity for each day throughout the hospital 
admission (day 2 until day 6). Independent t-test 
was also done to observe any different between 
numbers of activated monocyte with dengue 
severity from day 2 until day 6.
RESULT
Type of 
Dengue        
Frequency (n) Percentage (%)
DF                      17  53.1
DHF               15 46.9
Total              32  100
Table 1: Classification of Dengue Infection in 
subject
Table 1 shows that 53.1% of the subjects 
tested were classified under dengue fever and 
46.1% under dengue hemorrhagic fever, which 
consist of DHF patient grade 1 and grade 2.  
Days Mean Std. Deviation
2 334.9381 137.51644
3 304.8009 130.49518
4 314.4097 132.27171
5 290.0728 111.15938
6 262.9119 87.65818
Table 2:  Median number of Activated Monocyte 
for each day of acute dengue infection.
Table 2 shows the median number of 
activated monocyte for each day of acute 
dengue infection. We can observe the trend of 
decreasing mean number of activated monocyte 
from day 2 until day 6.
Days Mean(%) Std. Deviation(%)
2 92.69          7.71
3 90.15          9.46
4 93.17          5.27
5 92.43          7.34
6 90.06          8.68
Table 3: Percentage numbers of Activated 
Monocyte for each day of acute 
dengue infection.
Table 3 shows the percentage numbers of 
activated monocyte. Overall, there is a trend of 
decreasing number of activated monocyte from 
day 2 until day 6.
days correlation
Spearman’s rho
p-value
2 -0.312 0.082
3 -0.349 0.050*
4 +0.105 0.567
5 -0.319 0.075
6 +0.051 0.782
Table 4:  Spearman’s Correlation Test on 
median number of activated monocyte 
compared with dengue severity for 
each day of acute dengue infection.
( * = Significant value )
Table 4 shows the summary of Spearman’s 
Correlation Test on median number of activated 
monocyte compared with dengue severity for 
each day of acute dengue infection. From above, 
we can observe only median day 3 showed 
statistical significant result with a negative 
correlation between dengue severity and 
number of activated monocyte.
???????????????????????????????
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Table 2:  Median numb r of activ ted 
monocyte for each day of acute 
dengue infection.
Table 3: Percentage nu bers of activated 
monocyte for each day of acute 
dengue infection.
D
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Day severity mean Std. 
deviation
p-value
2 DF 376.52 35.89 0.40
DHF 287.81 28.71
3 DF 343.16 26.11 0.07
DHF 261.34 37.10
4 DF 305.44 35.50 0.70
DHF 324.57 30.60
5 DF 327.35 27.13 0.04*
DHF 247.82 25.11
6 DF 258.25 14.44 0.76
DHF 268.19 29.34
Table 5: Independent t-test for median number of activated monocyte.
( * = Significant value )
Figure 1: Graph showed the difference between DF and DHF median values on day 5.
?????????????????????????????????????????????????????????????????
??????????????????????????????????????
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Table 5 : Median number of activated monocytes.
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Table 5 displays the result of Independent 
t-test done on the median number of activated 
monocyte. There is a significant value day 5, 
suggesting that there is a difference in number 
of activated monocyte between DF and DHF 
patients today.
Figure 1 will show the distribution numbers 
of activated monocyte and the median value for 
DF and DHF patients.
There is a total of 32 participants in this 
study but some of the data is not present for 
day 5 and day 6. Participants for day 5 and day 
6 is originally 30 and 27 participants (should be 
a total of 32). Statistical analysis would not be 
valid if the participant data is not present so the 
mean of day 5 and day 6 is inserted into the data 
value. 
Table 4 shows the summary of Spearman’s 
Correlation Test on median number of activated 
monocyte compared with dengue severity 
for each day of acute dengue infection. Day 3 
of acute infection showed a significant result 
(p≤0.05) on negative correlation between 
numbers of activated monocyte with dengue 
severity. This means that as the number of 
activated monocyte decrease, more severe 
dengue infection will manifest as it is inversely 
proportional. This finding is in line with other 
previous study, which stated that low level of 
HLA-DR expression on monocyte will result in 
poorer outcome of sepsis patient and infectious 
complication in ruptured abdominal aortic 
aneurysms patients4. But, we do not obtain a 
similar result to previous study which mentioned 
that number of activated monocyte and greater 
number of DEN-infected cells associate with 
more severe dengue was because the method 
that was used were different. For this study, 
we used HLA-DR as marker and we checked 
for CD45, whereas the previous study chose to 
measure CD86+ for their activated monocyte 
marker and CD32 for the cytokines3.
Table 5 displays the result of Independent 
t-test done on the median number of activated 
monocyte. On day 5, there is a significant value 
(p<0.05) when DF patients was compared to DHF 
patients. Thus, there was a significant difference 
in the median numbers of activated monocyte 
with for DF patients (M=327.35, SD=27.13) and 
DHF patients (M=247.82, SD=25.11); t(30)=2.13, 
p=0.041. This means that there is a significant 
difference in number of activated monocyte 
on day 5 when compared between DF and DHF 
patients. Specifically, DF patients have higher 
median number of activated monocyte on this 
day. This is due to the fact that during severe 
dengue fever, monocyte deactivation may occur 
by HLA-DR down regulation and by Tissue Factor 
expression and consumption of coagulation 
factors5.
Based on the result that have been stated 
above, number of activated monocyte showed 
a negative correlation when compared to 
dengue severity in acute dengue infection. 
There are also a number of other risk factors 
that may contribute and help in determining the 
outcome of dengue infection, namely are like 
virus virulence as stated by Kurane (2006)6 and 
Noisakran (2007)1. Kurane (2006)6 stated that 
Southeast Asia DEN strain type 2 may contribute 
significantly toward disease progressiveness to 
DHF in different countries of Americas.
Other than that, infection by different 
secondary DEN strain may also exacerbate 
dengue severity 1. In this study, it was mentioned 
that secondary infection by DEN, especially by 
DEN of different serotype may lead to more 
serious outcome of dengue fever. Lei (2001)7 also 
mentioned that secondary infection by DEN type 
2 also possess more risk in developing DHF/DSS 
in patients, supported by the fact that patients 
with a secondary antibody response were twice 
as likely to have DHF, compared with those with 
a primary antibody response.
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CONCLUSION
There was a significant negative correlation 
between numbers of activated monocytes, 
marked by median value of HLA-DR intensity on 
day 3 of dengue infection.
There was a statistical difference between 
median number of activated monocyte for 
Dengue Fever and Dengue Hemorrhagic Fever 
on day 5.
There was no statistical correlation between 
percentage numbers of activated monocyte 
when compared with dengue severity.
SUGGESTION
The outcome of the study would be more 
favorable if there are more patients as subjects of 
study and higher grade of Dengue Hemorrhagic 
Fever (grade 3 and 4) to be included and enrolled 
in the study.
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